These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6098647)
1. Immunisation against Japanese encephalitis in Nepal: experience of 1152 subjects. Henderson A J R Army Med Corps; 1984 Oct; 130(3):188-91. PubMed ID: 6098647 [TBL] [Abstract][Full Text] [Related]
2. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus. Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study. Luo D; Yin H; Xili L; Song J; Wang Z Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706 [TBL] [Abstract][Full Text] [Related]
5. Encephalitis in Nepal: the visitation of the goddess of the forest. Henderson A J R Army Med Corps; 1983 Oct; 129(3):156-62. PubMed ID: 6319689 [TBL] [Abstract][Full Text] [Related]
6. A field trial of Japanese encephalitis vaccine produced in Thailand. Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722 [No Abstract] [Full Text] [Related]
7. Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases. Yamada A; Imanishi J; Juang RF; Fukunaga T; Okuno Y; Tadano M; Fukai K; Baba K; Yabuuchi H Vaccine; 1986 Mar; 4(1):32-4. PubMed ID: 3008460 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data. Intralawan P; Paupunwatana S Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563 [TBL] [Abstract][Full Text] [Related]
9. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys. Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959 [TBL] [Abstract][Full Text] [Related]
10. Intradermal boosting of Japanese encephalitis vaccination. Kitchener S; Baade L; Brennan L; Nasveld P J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061 [No Abstract] [Full Text] [Related]
11. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504 [TBL] [Abstract][Full Text] [Related]
12. Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response. Ramakrishna C; Desai A; Shankar SK; Chandramuki A; Ravi V Vaccine; 1999 Aug; 17(23-24):3102-8. PubMed ID: 10462246 [TBL] [Abstract][Full Text] [Related]
13. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs. García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A Viruses; 2017 May; 9(5):. PubMed ID: 28531165 [TBL] [Abstract][Full Text] [Related]
14. Further experience with Japanese encephalitis vaccine. Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043 [No Abstract] [Full Text] [Related]
15. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Kurane I; Takasaki T Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971 [TBL] [Abstract][Full Text] [Related]
17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region. Dubischar KL; Kadlecek V; Sablan JB; Borja-Tabora CF; Gatchalian S; Eder-Lingelbach S; Kiermayr S; Spruth M; Westritschnig K Pediatr Infect Dis J; 2017 Sep; 36(9):898-904. PubMed ID: 28430748 [TBL] [Abstract][Full Text] [Related]
20. Safety & efficacy of Japanese encephalitis vaccine produced in India. Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169 [No Abstract] [Full Text] [Related] [Next] [New Search]